Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,036 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 965
Recruiting: 553
Ph III recruiting: 55
Growth YoY: +9.2%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (701)

clinicaltrialsPublishedShowing 451–500 of 1,139 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07575412	SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS	not yet recruiting	Phase 2	180	The First Affiliated Hospital of Soochow UniversityOTHER	1	Jun 10, 2026	clinicaltrials
NCT07588360	Haplo-Cord HSCT for AML/MDS	recruiting	N/A	82	Fujian Medical University Union HospitalOTHER	1	Jun 10, 2026	clinicaltrials